dr. goy discusses btk inhibitors in mcl
Published 6 years ago • 113 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:13
dr. goy on research efforts with btk inhibitors in mcl
-
0:41
dr. goy on the potential utility of btk inhibitors as maintenance in mcl
-
2:16
dr. ruan discusses btk inhibitors in mcl
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
0:52
dr. goy on future treatment approaches in mcl
-
1:25
dr. goy discusses single-agent ibrutinib in mcl
-
1:02
dr. goy on the progression of mcl treatment
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:56
dr. rule on the role of btk inhibitors in mcl
-
2:07
dr. goy discusses intensive therapy for mcl
-
1:33
btk inhibitors improve responses relapsed/refractory mantle cell lymphoma
-
1:09
dr. goy discusses ibrutinib with venetoclax in mcl
-
1:15
dr. goy on treatment considerations in mcl
-
1:29
dr. wang on the benefit of btk inhibitors in mcl
-
1:00
dr. goy on acalabrutinib versus ibrutinib in mcl
-
0:55
dr. smith on safety profiles of btk inhibitors in mcl
-
1:20
dr. goy the evolution of treatment in relapsed/refractory mcl
-
1:31
dr. goy on treating older patients with mcl
-
1:06
dr. goy on promising data with acalabrutinib in mcl